Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent HPV vaccination after treatment of anal intraepithelial neoplasia in HIV-positive men
NL-OMON44810Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anal intraepithelial neoplasia (AIN) and human papillomavirus infection comparing Gardasil with Placebo (2 arms). Primary endpoint: Cumulative recurrence of high-grade anal intraepithelial neoplasia. Started Apr 2014; status: active, not recruiting.
02
Drugs
qHPV vaccine
03
Conditions
anal intraepithelial neoplasia (AIN)human papillomavirus infection
Beyond the preview
Go deeper on NL-OMON44810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44810.